• Integration of 1-System platform nearing completion
• Revenue growth exceeding projections, overhead costs reduced
• Expanding business pipeline with strategic partnerships

Careteq Limited (ASX: CTQ), a clinical healthtech company specialising in medication management and clinical governance solutions, has provided a quarterly update on its Q3 FY25 activities and Appendix 4C. Key highlights include the integration of the 1-System platform for Embedded Health Solutions (EHS) and HMR Referrals nearing completion, with roll-out expected in Q4. The company has also contained net cash outflows from operating activities at $0.25 million, reflecting operational discipline and setting the foundation for further efficiencies. Year-to-date revenue from continuing operations has exceeded growth projections, while overhead costs have been reduced by approximately 10% compared to the prior year. Careteq has maintained positive underlying EBITDA from continuing operations, with momentum expected to continue into Q4 and FY26. The company has accelerated its market penetration strategy, evidenced by increased traction across multiple healthcare networks, including a strategic partnership with Medic Alert and growing engagement from aged care providers and GP networks. Key priorities for Q4 FY25 include realising cost synergies post 1-System platform roll-out, expanding strategic partnerships, introducing new service offerings, and implementing further operational efficiencies.

The company expects to deliver sustained growth and shareholder value, supported by its streamlined operations and disciplined cost management.

Careteq's key priorities for Q4 FY25 include realising cost synergies post 1-System platform roll-out, continuing to expand strategic partnerships in the aged care and home care sectors, introducing new service offerings leveraging the 1-System platform capabilities, and implementing further operational efficiencies to extend the company's cash runway.